Synapsium
The current process for discovering, developing, and sourcing novel, highly specialized molecular compounds for advanced industrial applications (e.g., next-gen batteries, pharmaceuticals, new materials) is incredibly slow, resource-intensive, and fragmented. Labs often lack the specific expertise or equipment for certain syntheses, and researchers struggle to find reliable partners for bespoke molecular development, leading to stalled innovation and wasted R&D budgets.
1Wackiness
24-36 months. Significant R&D is required for the core AI matching algorithms, computational chemistry integration, and developing a secure, verifiable IP transfer protocol, alongside onboarding an initial critical mass of both requesters and synthesis providers.Transactional fee (commission) on each successful synthesis project facilitated through the platform, charged to both the requester and the synthesizing lab. Tiered subscription services for advanced analytics, predictive synthesis insights, and expedited matching.

The Solution

Synapsium uses proprietary AI and computational chemistry models to create a global marketplace. Researchers and companies submit detailed requests for novel molecular structures or compounds with specific functional properties. Synapsium's platform intelligently matches these requests with a network of specialized synthesis labs, academic institutions, and robotic chemistry platforms, facilitating secure IP exchange, synthesis proposal generation, and transactional oversight.

Confidential Investment MemoIsraeli Deep Tech

"The technical hurdles to intelligently connect bespoke molecular synthesis capabilities with complex R&D demands are immense. Synapsium's proposed AI-driven matching and secure IP infrastructure, if proven robust, could create an impenetrable moat. This isn't just a platform; it's a computational chemistry command center for global molecular innovation, demanding military-grade precision and algorithmic superiority to succeed."

— Partner at Orion Zenith Partners

* This is a work of fiction. Any resemblance to actual persons, living or dead, or actual VCs is purely coincidental.